HCC blog

Pharmacist Jobs Statistics

Statistics regarding the state of the current job market for pharmacists that were released in the most recent report by the US Department of Labor (Bureau of Labor Statistics) on June 17, 2019 show some interesting results when one is considering pharmacy as a career. For those already practicing in the pharmacy profession, it also … Continue reading Pharmacist Jobs Statistics

Emergency Relief Pharmacists

Needing temporary pharmacists during emergency situations can sometimes pose what seems like insurmountable obstacles to the pharmacy owner and manager. Last year the hurricanes in both Texas and Florida had brought up numerous discussions with clients regarding situations that can occur when an emergency relief pharmacist can be of critical importance to your drugstore even … Continue reading Emergency Relief Pharmacists

Pharmacy Staffing, Recruitment and Placement Services

Healthcare Consultants Pharmacy Staffing is recognized as a national leader in regards to pharmacy staffing, recruitment and placement services, plus has been known as a “full service” pharmacy staffing company since 1989 now. With more than 30+ years in the pharmacy staffing, recruitment and placement business, HCC is acknowledged throughout the USA for our ability … Continue reading Pharmacy Staffing, Recruitment and Placement Services

Infusion Partners Received an FDA Warning Letter

After the 483 Form that we previously discussed is responded to by the outsourcing facility, the FDA has the option to then send an FDA Warning Letter if they’re not satisfied with the response and/or action plan that’s presented to them. In March of 2019 the FDA issued such an actual Warning Letter to Infusion … Continue reading Infusion Partners Received an FDA Warning Letter

FDA 483 Actions

After discussing the difference between an FDA Form 483 and an FDA Warning Letter, it may perhaps be worthwhile to take a closer look at some of the most recent actions that have occurred (including new FDA 483 Forms and Warning Letters). Although perhaps a couple of months have already passed, but March of 2019 … Continue reading FDA 483 Actions

Recent FDA 503 Actions

Last month the The FDA (U.S. Food and Drug Administration) was extremely busy taking actions in regards to 503B outsourcing facilities and 503A compounding pharmacies. A review of many of these FDA 503 actions indicates an increased and aggressive program aimed at both outsourcing facilities and compounding pharmacies that included numerous onsite inspections, warning letters, … Continue reading Recent FDA 503 Actions

FDA Form 483

Many compounding pharmacies have been asking “what is the difference between an FDA Form 483 and an FDA Warning Letter?”. The FDA (U.S. Food and Drug Administration) has been extremely busy and is dramatically stepping up their efforts at inspecting 503A compounding pharmacies across the nation. Officially named by the FDA as a Notice of … Continue reading FDA Form 483


GHRP is short for “Growth Hormone Releasing Peptide” and is in the category of drugs known as Growth Hormone Secretagogues (GHS). These peptides actually stimulate the body’s natural release of the naturally occurring growth hormone (GH), primarily by stimulating the pituitary gland to produce more GH. The GHRPs of most interest are GHRP-2, GHRP-6, Hexarelin, … Continue reading GHRP

503A Pharmacies

Compounding pharmacies and 503A specialty pharmacies have been the center of  FDA (U.S. Food & Drug Administration) focus ever since the tragic 64 deaths associated with the NECC (New England Compounding Center) occurred back in 2012. The 64 patients that died and the 750+ others that were injured due to the contaminated drugs compounded by … Continue reading 503A Pharmacies

503B Outsourcing Facilities – Are You in Compliance?

A lot of discussion about how FDA 503B inspections are having a huge impact on 503B outsourcing facilities and their operations. It’s easy to see that being prepared with your 503B P&P manual up to date is the key to a successful inspection results and compliance audit outcomes. The Drug Quality and Security Act, signed … Continue reading 503B Outsourcing Facilities – Are You in Compliance?